Treatment Options for Vitiligo and Pityriasis Alba
For vitiligo, first-line treatment includes potent topical corticosteroids for limited areas and narrowband UVB phototherapy for widespread disease, while pityriasis alba responds well to topical calcineurin inhibitors and moisturizers. 1
Treatment for Vitiligo
First-Line Therapies
Topical Treatments
Potent or very potent topical corticosteroids
Topical calcineurin inhibitors (tacrolimus/pimecrolimus)
Phototherapy
- Narrowband UVB (NB-UVB)
- Preferred phototherapy option due to superior efficacy and safety
- Recommended for:
- Widespread vitiligo
- Cases not manageable with topical treatments
- Especially beneficial for darker skin types
- Safety limit: Maximum 200 treatments for skin types I-III 2, 1
- Should be monitored with serial photographs every 2-3 months 2
- Narrowband UVB (NB-UVB)
Second-Line and Combination Therapies
Combination Approaches
Surgical Options (for stable, treatment-resistant vitiligo)
- Split-skin grafting
- Autologous epidermal suspension
- Suction blister transfer 1
Treatment by Anatomical Location
- Face: First choice is topical calcineurin inhibitors; alternatives include intermittent potent corticosteroids 1
- Body: First choice is intermittent potent corticosteroids; for widespread areas, consider NB-UVB 1
- Hands/Feet: Combination therapy (corticosteroids + NB-UVB) recommended due to treatment resistance 1
Treatment for Pityriasis Alba
First-Line Approaches
Additional Options
Adapalene 0.1% cream/gel
- Apply at night, starting 2-3 times weekly and gradually increasing
- Beneficial for post-inflammatory hyperpigmentation 1
Regular moisturization
- Essential for management as condition is often associated with dry skin
Important Considerations
Monitoring and Follow-up
- Use serial clinical photographs to track progress
- Follow-up every 2-3 months
- Consider maintenance therapy to reduce relapse risk (>40% lose response after 1 year without treatment) 1
Psychological Support
- Assessment of psychological and quality of life effects should be made
- Offer appropriate psychological interventions 2, 1
Common Pitfalls to Avoid
- Prolonged continuous use of potent corticosteroids (risk of atrophy)
- Using calcipotriol as monotherapy (less effective)
- Inadequate treatment duration
- Neglecting psychological aspects of the condition
- Failing to adjust treatment based on anatomical location response 1
Special Populations
- Children under 18: Consider potent topical steroids for a trial period of no more than 2 months; tacrolimus/pimecrolimus are safer alternatives 2
- Very fair skin (types I-II): Consider cosmetic camouflage and sunscreens rather than active treatment 1
- Extensive vitiligo in darker skin types: Depigmentation with p-(benzyloxy)phenol may be considered as a last resort 1